Fasting Bioavailability Study of Mylan's Revefenacin Inhalation Solution

Clinical trial NCT05207111 · COMPLETED

Trial details

NCT number: NCT05207111
Sponsor: Mylan Pharma UK Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Bioavailability Study

Start date: 2021-09-23
Primary completion: 2021-09-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.